3//SEC Filing
KPCB China Holdings II, Ltd. 3
Accession 0001437749-18-022822
CIK 0000946486other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:34 PM ET
Size
10.1 KB
Accession
0001437749-18-022822
Insider Transaction Report
Form 3
KPCB China Associates II, L.P.
10% Owner
Holdings
- 4,336,790
Common Stock
Ivy Blue Holdings Ltd
10% Owner
Holdings
- 4,336,790
Common Stock
KPCB China Fund II, L.P.
10% Owner
Holdings
- 4,336,790
Common Stock
KPCB China Holdings II, Ltd.
10% Owner
Holdings
- 4,336,790
Common Stock
Footnotes (1)
- [F1]The securities of the Issuer reported in this Form 3 are directly held by Ivy Blue Holdings Limited. KPCB China Fund II, L.P. is the 100% owner of Ivy Blue Holdings Limited. KPCB China Associates II, L.P. is the general partner of KPCB China Fund II, L.P. KPCB China Holdings II, Ltd. is the general partner of KPCB China Associates II, L.P. The directors of KPCB China Holdings II, Ltd. are Brook Byers, Wen Hsieh, James Huang and Theodore Schlein. By virtue of these relationships, Brook Byers, Wen Hsieh, James Huang and Theodore Schlein may be deemed to indirectly beneficially own the securities held by Ivy Blue Holdings Limited, however each disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Documents
Issuer
WINDTREE THERAPEUTICS INC /DE/
CIK 0000946486
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001533828
Filing Metadata
- Form type
- 3
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 4:34 PM ET
- Size
- 10.1 KB